My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
Blog Home All Blogs
Search all posts for:   


View all (318) posts »

Covance and Eli Lilly Announce Their ASAP Award for a Long-Established Alliance; ASAP Formally Announces 2014 Alliance Excellence Award Winners

Posted By Administration, Friday, June 20, 2014
Originally posted on 5/13/2014

In March at the ASAP Global Alliance Summit in Scottsdale, Ariz. USA, Covance Inc., a clinical research organization, and pharmaceutical company Eli Lilly and Co. received ASAP’s 2014 Alliance Excellence Award for a Long-Established Alliance. The awards committee recognized these two companies for their transformative collaboration that has infused greater efficiency and quality into the drug development process and has enabled new medicines to advance to market sooner. Last week, Covance and Lilly issued a press release announcing the honor.

In 2008, Lilly transferred its Greenfield, Ind. facility and about 250 employees to Covance. Since then, with the addition of 300 new jobs and seven new services, Covance and Lilly have completed more than 11,000 studies in support of discovery research, and more than 500 toxicology studies supporting nearly 50 different molecules. More than 800 studies have been conducted spanning late stage development of products. Covance’s Greenfield site now supports development innovation for over 150 biopharmaceutical companies, in addition to Lilly. Their Greenfield operations plus related effects are estimated to have added over 550 jobs, $35 million in annual wages, and $102 million in annual output to the economy of Indiana.

“We are five years strong into our industry-pioneering alliance with Covance, designed to support the transformation of our R&D model,” said Andrew Dahlem, Ph.D., vice president and chief operating officer, Lilly Research Laboratories (LRL) and LRL Europe. “Working together, we have improved research and development efficiencies, reduced costs, and accelerated drug development timelines by as much as 50 percent. Ultimately, we are measuring success against our most important goal – to speed quality, innovative medicines to patients.” Added John Watson, President, Strategic Partnering, and Chief Commercial Officer at Covance, “As a result of our connected and forward-thinking partnership, the alliance continues to exceed expectations and deliver enormous value to both Lilly and Covance.”

Covance, headquartered in Princeton, N.J., is a drug development services company with more than 12,500 employees located in over 60 countries. Lilly is a global healthcare leader that pledges that it unites caring with discovery, and is committed to creating high-quality medicines that meet real needs.

This week, ASAP issued its own official press release announcing the winners of the 2014 Alliance Excellence Awards. The five other awards were as follows:
  • Cisco and NetApp won the award for Alliance Excellence in an emerging alliance, as they develop their “FlexPod” integrated infrastructure tool;
  • Sanofi and DNDi (Drugs for Neglected Diseases initiative) received the Alliance for Social Responsibility award, as they combat malaria without patenting their drug;
  • Cisco also won the award for Innovative Alliance Best Practice, with its own “automated online business consulting for partners”;
  • KPMG received the Excellence in an Alliance Program award, for its People and Change project that focuses on three key components of an alliance program;
  • ASAP Toronto chapter was recognized for Program Innovation in creating and implementing a marketing plan, with personal invitations to events as well as use of social media, and fueled by a rejuvenated board.
As ASAP CEO Mike Leonetti told the conference audience, “An ASAP Alliance Excellence Award is the most prestigious honor for business collaborators—the world’s premier award celebrating advancements in the management of strategic alliances.”

This post has not been tagged.

Share |
Permalink | Comments (0)
For more information email us at or call +1-781-562-1630